Genetic Polymorphism for the Gene Encoding Endoplasmic Reticulum Aminopeptidase-1 (ERAP-1) in Iraqi Patients with Ankylosing Spondylitis

Article Sidebar

2-Oct-5775.pdf
Published Sep 30, 2024
DOI: https://doi.org/10.18103/mra.v12i9.5775

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Muataz Mohammed Al-Taee
Department of Biotechnology, College of Science, University of Baghdad, Baghdad, Iraq; Department of Medical Laboratory Technology, AL- Nisour University College, Baghdad, Iraq.

Abstract

Ankylosing spondylitis (AS) is a common, highly heritable inflammatory arthritis affecting primarily the spine and pelvis. This study was aimed to investigate the relationship between the rs27044 polymorphism in Endoplasmic reticulum aminopeptidase-1 (ERAP-1) with the susceptibility and severity of AS correlated with some biochemical markers such as hematological parameter (Erythrocytes sedimentation rate (ESR)) and immunological parameters (C-reactive protein (CRP), Human leukocyte antigen-B27 (HLA-B27), Interlukin-6 (IL-6) and Interlukin-23 (IL-23)), and oxidative stress parameters (Glutathione (GSH) and Malondialdehyde (MDA)) in a sample of Iraqi population. A total of 60 blood samples were collected from AS patients requited Rheumatology Consultation Clinic in Baghdad Teaching Hospital in Baghdad Governorate. Those patients are males and females with age ranged between 26- 32 years for early diagnosed patients (10 samples) and other medically treated patients with age ranged between 22-52 years (50 samples). The rest (30 blood samples) were collected from healthy controls with age ranged between 16-68 years. Results showed that there is a significant increase in Erythrocytes Sedimentation Rate (ESR) as a hematological parameter in newly diagnosed and medically treated patients. For the immunological parameters, results showed that C-reactive protein (CRP) was detected in all serum samples taken from newly diagnosed patients, and 80% positive were detected in medically treated patients in comparison with 100% negative results in healthy controls. On the other hand, Human leukocyte antigen-B27 (HLA-B27) was also detected in all serum samples taken from newly diagnosed patients and 76% positive were recorded in medically treated patients as compared with negatively resulted in healthy controls. For the Interleukins (IL-6 and IL-23), results showed that there is a significant increase in levels of both interleukins in serum samples of newly diagnosed patients compared with healthy controls and medically treated patients, in which any significant difference was recorded. Results of oxidative stress parameters showed that there is a significant decrease in Glutathione (GSH) levels in serum samples of newly diagnosed patients compared with its level in serum sample of controls and medically treated patients, in which significantly not different. Results also showed that there is a significant increase in Malondialdehyde (MDA) levels in serum samples of newly diagnosed patients compared with its levels in healthy controls and medically treated patients, in which no significant difference in MDA levels in serum samples of both groups. Genetic polymorphism of ERAP-1 gene (rs27044 SNP) in exon15 within chromosome 5 was studied. The genomic DNA was extracted from blood samples for controls and AS patients at concentrations of extracted DNA was ranged between 100-200 ng/μl with purity of 1.8-2.0. Exon 15 was amplified by using specific primers results showed that a single band of 298 bp was obtained after electrophoresis on agarose gel (2%) represents the complete nucleotide sequence of exon 15. Results showed that the single nucleotide polymorphism (rs27044) was cSNP in all controls, while gSNP was found in 64% of polymorphic AS patients with a significant difference than non-polymorphic AS patients (36%).

Keywords: Endoplasmic reticulum aminopeptidase-1 (ERAP1) gene, ankylosing spondylitis

Article Details

How to Cite
AL-TAEE, Muataz Mohammed. Genetic Polymorphism for the Gene Encoding Endoplasmic Reticulum Aminopeptidase-1 (ERAP-1) in Iraqi Patients with Ankylosing Spondylitis. Medical Research Archives, [S.l.], v. 12, n. 9, sep. 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5775>. Date accessed: 04 oct. 2024. doi: https://doi.org/10.18103/mra.v12i9.5775.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 12 No 9 (2024): Vol 12 No 9 (2024): September ISSUE, Issue 9, VOl.12
Section
Research Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

• Ghasemi-rad, M.; Attaya, H.; Lesha, E.; Vegh, A.; Maleki-Miandoab, T.; Nosair, E.; Sepehrvand, N.; Davarian, A.; Rajebi, H.; Pakniat, A.; Fazeli, S. and Mohammadi, A. (2015). Ankylosing spondylitis: A state of the art factual backbone. World J Radiol September 28; 7(9): 236-252.

• Reveille, J.D. (2015). Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol. 34(6): 1009–1018. doi: 10. 1007/s 10067-015-2949-3.

• Reveille, J.D.; Sims, A.M.; Danoy, P.; Evans, D.M.; Leo, P. and Pointon, J.J. et al. (2010). Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet; 42(2):123–7.

• Kochan, G.; Krojer, T. and Harvey, D. (2011). Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 19, pp.7745–7750.

• Saveanu, L.; Carroll, O. and Lindo, V. (2005). Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nature Immunology, vol.6, no.7, pp.689 –697.

• Cui, X.; Rouhani, F.N.; Hawari, F. and Levine, S.J. (2003). An aminopeptidase, ARTS-1, is required for interleukin-6receptor shedding. Journal of Biological Chemistry. vol. 278, no. 31, pp. 28677–28685.

• Goto, Y.; Ogawa, K.; Hattori, A. and Tsujimoto, M. (2011). Secretion of endoplasmic reticulum aminopeptidase 1 is involved in the activation of macrophages induced by lipopolysaccharide and interferons. Journal of Biological Chemistry. vol. 286, no. 24, pp.21906–21914.

• Burton, P.R.; Clayton, D.G.; Cardon, L.R.; Craddock, N.; Deloukas, P.; Duncanson, A.; Kwiatkowski, D.P.; McCarthy, M.I.; Ouwehand, W.H. and Samani, N.J. et al. (2007). Association scans of 14,500 non-synonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet., 39, 1329–1337.

• SAS, (2012). Statistical Analysis System, User's Guide. Statistical. Version 9.1th ed. SAS. Inst. Inc. Cary. N.C. USA.

• Wolfe, F. and Pincus, T. (2001). The level of inflammation in rheumatoid arthritis is determined early and remains stable over the long term course of the illness. J Rheumatol; 28:1817-1824.

• Wallis, D.; Haroon, N.; Ayearst, R.; Carty, A. and Inman, R.D. (2013). Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? J Rheumatol. 40(12):2038–2041. [PubMed: 24187102].

• Dixon, J.S.; Bird, H.A. and Wright, V. (1981). A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis. Annals of the Rheumatic Diseases, 40, 404-408.

• Benjamin, M. and Ralphs, J.R. (2001). Entheses the bony attachments of tendons and ligaments. Ital J Anat Embryol; 106: 151­157 [PMID: 11729950].

• Londono, J.; Romero-Sanchez, M.C.; Torres, V.G.; Bautista, W.A.; Fernandez, D.J.; Quiroga, J.A.; Valle-Oñate, R.; Santos, A.M. and Medina, J.F. (2012). The association between serum levels of potential biomarkers with the presence of factors related to the clinical activity and poor prognosis in spondyloarthritis. Rev Bras Reumatol; 52(4):529-544.

• Spoorenberg, A.; van der Heijde, D.; de Klerk, E.; Dougados, M.; de Vlam, K.; Mielants, H.; van der Tempel, H. and van der Linden, S. (1999). Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. 26(4):980–984. [PubMed: 10229432].

• Przepiera-Bwdzak, H.; Fischer, K. and Brzosko, M. (2015). Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome. Hindawi Publishing Corporation Mediators of Inflammation Volume 2015, Article ID 785705, 7 pages. http://dx.doi.org/10.1155/2015/785705

• Londoño, J.; González, L.; Ramírez, A.; Santos, P.; Avila, L. and Santos, A. et al (2005). Caracterización de las espondiloartropatías y determinación de factores de mal pronostico en una población de pacientes colombianos. Rev Colomb Reumatol, 12(3):195–207.

• Khan, M.A. and Kellner, H. (1992). Immunogenetics of spondylo-arthropathies. Rheum Dis Clin North Am, 18(4):837–64.

• Chen, W.S.; Chang, Y.S.; Lin, K.C.; Lai, C.C.; Wang, S.H. and Hsiao, K.H. (2012). Association of serum interleukin-17 and interleukin-23 levels with disease activity in Chinese patients with ankylosing spondylitis. J Chin Med Assoc. 75(7):303–308. [PubMed: 22824043].

• Tarner, H.; Müller-Ladner, U.l.f.; Uhlemann, C. and Lange, U. (2009). The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis. Clin Rheumatol, 28:397–402.

• Cauli, A. and Mathieu, A. (2012). Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis. Journal of Rheumatology, vol.39,no.89,pp.15–18.

• Hayer, S.; Niederreiter, B.; Nagelreiter, I.; Smolen, J. and Redlich, K. (2010). Interleukin 6 is not a crucial regulator in an animal model of tumour necrosis factor-mediated bilateralsacroiliitis. Annals of the Rheumatic Diseases, vol.69,no.7, pp.1403–1406.

• Choy, E.H. and Panayi, G.S. (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med Mar 22; 344(12):907-916.

• Singh, A.K.; Misra, R. and Aggarwal, A. (2011). Th-17 associated cytokines in patients with reactive arthritis/undifferentiated spondylo-arthropathy. Clinical Rheumatology, vol.30, no.6, pp.771–776.\

• Kalpakcioglu, B. and Senel, K. (2008). The interrelation of glutathione reductase, catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in the pathogenesis of rheumatoid arthritis. Clin Rheumatol. 27(2):141-5.

• Pompella, A.; Visvikis, A.; Paolicchi, A.; De Tata, V.; Casini, A.F. (2003). The changing faces of glutathione, a cellular protagonist. Biochem. Pharmacol. 66, 1499-1503. 10. 1016/S0006-2952 (03) 00504-5.

• Feijóo, M.; Túnez, I.; Ruiz, A.; Tasset, I.; Muñoz, E. and Collantes, E. (2010). Oxidative stress biomarkers as indicator of chronic inflammatory joint diseases stage. Reumatol Clin; 6(2):91–94.

• Cuzzocrea, S.; Thiemermann, C. and Salvemini, D. (2004). Potential Therapeutic Effect of Antioxidant Therapy in Shock and Inflammation. Current Medicinal Chemistry 11, 1147-1162.

• Halliwell, B. and Gutteridge, J.M.C. (2003). Free Radicals in Biology and Medicine. (Oxford University Press: Oxford, UK).

• Ozgocmen, S.; Sogut, S.; Ardicoglu, O.; Fadillioglu, E.; Pekkutucu, I. and Akyol, O. (2004). Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24, 80-83.

• Boesenberg-Smith, K.A.; Mohammad, M.; Pessarakli, M.D. and Donna, M.W. (2012). Assessment of DNA Yield and Purity: an Overlooked Detail of PCR Trouble shoots in. Clinical Microbiology Newsletter. Vol. 34, No. 1.

• Zambrano-Zaragoza, J.F.; Agraz-Cibrian, J.M.; González-Reyes, C.; Jesús-Durán, A. and Vibanco-Pérez, N. (2013). Ankylosing Spondylitis: From Cells to Genes. Hindawi Publishing Corporation International Journal of Inflammation. Article ID501653, 16 pages.

• Wang, C.; Ho, H.; Chang, S.; Wu, Y.; Lin, J.; Chang, P.; Wu, J. and Chen, J. (2012). ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Research and Therapy, 14:R125.

• Alvarez-Navarro, C.l. and López de Castro, J.A. (2014). ERAP1 structure, function and pathogenetic role in ankylosing spondylitis and other MHC-associated diseases. Mol Immunol. Jan; 57(1):12-21.

• Szczypiorska, M.; Sanchez, A.; Bartolome, N.; Arteta, D.; Sanz, J. and Brito, E. (2011). ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. Rheumatology (Oxford). 50:1969-75.

• Harvey, D.; Pointon, J.J.; Evans, D.M.; Karaderi, T.; Farrar, C.; Appleton, L.H.; Sturrock, R.D.; Stone, M.A.; Oppermann, U.; Brown, M.A. and Wordsworth, B.P. (2009). Investigating the genetic association between ERAP1 and ankylosing spondylitis. Human Molecular Genetics 18, 4204–4212.